Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Ikkou Group CoTSE:3353 +0.53%68 Median PS Value is 円4,772.99 as of Jul. 15, 2026, which is 100% below its 10-year median of 0.81. GuruFocus rates TSE:3353 with a GF Score™ of 68/100 and a GF Value™ of 円3,534.01 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 416 Conglomerates companies, Medical Ikkou Group Co ranks better than 78.12% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Medical Ikkou Group Co's Median PS Value or its related term are showing as below:
TSE:3353'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.49 Med: 0.81 Max: 1.61
Current: 0.6
During the past 13 years, the highest Price to Median PS Value of Medical Ikkou Group Co was 1.61. The lowest was 0.49. And the median was 0.81.
TSE:3353's Price-to-Median-PS-Value is ranked better than 78.12% of 416
companies
in the Conglomerates industry
Industry Median: 0.97
vs TSE:3353: 0.60
Medical Ikkou Group Co (TSE:3353) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Medical Ikkou Group Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2841.00
/
4,772.99
=
0.60
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Ikkou Group Co Median PS Value Related Terms
Medical Ikkou Group Co Median PS Value Historical Data
* Premium members only.
The historical data trend for Medical Ikkou Group Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Medical Ikkou Group Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Ikkou Group Co Price-to-Median-PS-Value vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Medical Ikkou Group Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Medical Ikkou Group Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.3268.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Ikkou Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was 円14605.415.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Ikkou Group Co (TSE:3353) has a Median PS Value of 円4,772.99 as of Jul. 15, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Medical Ikkou Group Co and its competitors. This is 589158% above median its historical median of 0.81. Over the past decade, Medical Ikkou Group Co's Median PS Value has ranged from 0.49 to 1.61. According to the industry distribution chart, Medical Ikkou Group Co ranks #91 out of 416 companies in the Conglomerates industry, placing it in the top 21.9%.
Is Medical Ikkou Group Co's Median PS Value too high?
Medical Ikkou Group Co's current Median PS Value of 円4,772.99 is 589158% above median its 10-year median of 0.81. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 1.61. Based on the distribution chart, Medical Ikkou Group Co ranks #91 out of 416 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, Medical Ikkou Group Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's Median PS Value compare to HON and MMM?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #91 out of 416 companies for Median PS Value. This places Medical Ikkou Group Co in the top 22% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.97. Historically, Medical Ikkou Group Co's own Median PS Value has ranged from 0.49 to 1.61 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Conglomerates company?
The median Median PS Value among Conglomerates companies is 0.97, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Medical Ikkou Group Co and its competitors. For the Conglomerates industry, the median Median PS Value is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current Median PS Value is 円4,772.99, which is 589158% above median its own 10-year median of 0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,534.01, compared to a current price of 円2,841.00 — trading 19.6% below its estimated fair value. The current Median PS Value is 円4,772.99, which is 589158% above median its 10-year median of 0.81. Medical Ikkou Group Co's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current Median PS Value is 円4,772.99 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued.
The current stock price of 円2,841.00 is trading 19.6% below its estimated GF Value™ of 円3,534.01.
GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.
Key valuation signals for TSE:3353:
Median PS Value: 円4,772.99 (589158% above median its 10-year median of 0.81)
GF Value™: 円3,534.01 vs. price of 円2,841.00 (19.6% below fair value)
No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
68GF Score
Get the complete analysis for TSE:3353
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3353 has been successfully added to your 
